Clinical trial
Intensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine…
NCT00084591 · Fox Chase Cancer Center, Other · Completed
Key facts
| NCT number | NCT00084591 |
|---|---|
| Title | Intensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine Before Surgery in Treating Patients With Locally Advanced Rectal Cancer |
| Official title | Phase I Study of Preoperative Intensity Modulated Radiation Therapy (IMRT) With Incorporated Boost and Oral Capecitabine in Locally Advanced Rectal Cancer |
| Lead sponsor | Fox Chase Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | capecitabine, conventional surgery, neoadjuvant therapy, radiation therapy |
| Start date | Dec 1, 2003 |
| Completion | Feb 1, 2007 |
| First posted | Jun 11, 2004 |
| Last update posted | Feb 12, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: